Bath & Body Works (NYSE:BBWI – Get Free Report) had its price target decreased by research analysts at UBS Group from $19.00 to $17.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential downside of 7.48% from the stock’s previous close.
A number of other equities research analysts also recently weighed in on the company. Deutsche Bank Aktiengesellschaft set a $22.00 target price on Bath & Body Works in a report on Thursday. TD Cowen raised their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. JPMorgan Chase & Co. lifted their price objective on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research note on Tuesday, August 18th. Barclays set a $22.00 target price on shares of Bath & Body Works and gave the company an “equal weight” rating in a research report on Thursday. Finally, Jefferies Financial Group raised their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Four research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and an average target price of $22.29.
Check Out Our Latest Stock Report on BBWI
Bath & Body Works Stock Down 2.8%
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the business earned $0.30 EPS. The firm’s revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities research analysts anticipate that Bath & Body Works will post 2.63 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Global Retirement Partners LLC bought a new stake in shares of Bath & Body Works during the fourth quarter worth about $31,000. Activest Wealth Management bought a new position in Bath & Body Works in the 4th quarter valued at about $32,000. Geneos Wealth Management Inc. boosted its stake in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC boosted its stake in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after purchasing an additional 567 shares during the last quarter. Finally, Danske Bank A S bought a new stake in Bath & Body Works during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.
More Bath & Body Works News
Here are the key news stories impacting Bath & Body Works this week:
- Positive Sentiment: BBWI reported adjusted earnings of $0.62 per share, well above the $0.24 consensus estimate, while revenue of $1.51 billion modestly exceeded expectations. Digital demand for body-care products and home fragrances helped offset weaker store traffic. Bath & Body Works lifts annual profit forecast as digital demand offsets weak store traffic
- Positive Sentiment: Management raised its fiscal 2026 adjusted EPS outlook to $2.60-$2.80 from $2.40-$2.65, above the roughly $2.56 analyst consensus. The company also cited transformation progress, digital growth and a focus on cost savings and cash generation as longer-term potential catalysts. Bath & Body Works Raises Earnings Outlook on Higher Profit
- Neutral Sentiment: Some analysts argue that BBWI’s valuation and improving profitability are not fully reflected in the stock, while the broader investment debate remains centered on whether the turnaround can continue. Bath & Body Works: The Market Is Ignoring This Turnaround Story – For Now
- Negative Sentiment: Third-quarter adjusted EPS guidance of $0.07-$0.12 is substantially below the $0.27 consensus estimate. Revenue guidance of $1.6-$1.7 billion also implies limited growth, adding to concerns about weak store traffic and uneven consumer demand. Bath & Body Works results top expectations, lower third quarter earnings expected
- Negative Sentiment: Morgan Stanley lowered its BBWI price target to $20 from $22 and maintained an “equal weight” rating, signaling limited conviction in the near-term upside. Second-quarter revenue also declined 2.3% year over year. Morgan Stanley price-target update
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Strategy’s $1.59B Gamble: Checkmate at $80K?
- Semtech Stock Rallies on Strong Q2 Results and Raised Guidance
- Marvell’s Big AI Test Comes One Day After NVIDIA’s Blowout Quarter
- NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
